Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ROFLUMILAST vs ROSIGLITAZONE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ROFLUMILAST vs ROSIGLITAZONE: Safety Overview

Metric ROFLUMILAST ROSIGLITAZONE
Total FAERS Reports 2,700 45,976
Deaths Reported 645 4,661
Death Rate 23.9% 10.1%
Hospitalizations 625 23,675
Average Patient Age 68.8 yrs 60.2 yrs
% Female Patients 56.3% 42.8%
FDA Approval Date Apr 17, 2023 Jan 25, 2013
Manufacturer Aurobindo Pharma Limited N/A
Route ORAL N/A
Marketing Status Prescription Discontinued